Medicine and Dentistry
Vaccine
100%
Mutant
100%
Cytotoxic T-Cell
100%
Melanoma
100%
Antigen Specificity
100%
Dendritic Cell
100%
Neoplasm
85%
Survival
71%
Therapeutic Procedure
42%
Tumor Progression
42%
In Vitro
28%
Interferon
28%
Development
14%
Immune Response
14%
Peptide
14%
Cancer Cell
14%
Exploratory Behavior
14%
Recognition
14%
Enzyme Linked Immunosorbent Assay
14%
Oncogene
14%
Targeted Therapy
14%
Sensitization
14%
T-Cell Response
14%
Melanoma B16
14%
Antigen Presenting Cell
14%
Enzymes
14%
Ovalbumin
14%
Measurement
14%
Immunology and Microbiology
Cytotoxic T-Cell
100%
Dendritic Cell
100%
Antigen Specificity
100%
Mutant
100%
Murine
100%
Vaccine
100%
Survival
71%
Growth
42%
Interferon Type I
28%
Vaccination
28%
Antigen-Presenting Cell
14%
Enzyme-Linked Immunosorbent Assay
14%
Immune Response
14%
Development
14%
Recognition
14%
Cancer Cell
14%
Sensitization
14%
Time
14%
Oncogene
14%
Pharmacology, Toxicology and Pharmaceutical Science
Murine
100%
Melanoma
100%
Vaccine
100%
CD8 Antigen
100%
Antigen
100%
Neoplasm
85%
Survival
71%
Tumor Growth
42%
Interferon
28%
Vaccination
28%
Sensitization
14%
Enzyme-Linked Immunosorbent Assay
14%
Malignant Neoplasm
14%
Peptide
14%
Ovalbumin
14%
Melanoma B16
14%
Enzymes
14%